AI brief of an SEC Form 8-K · Mobia Medical, Inc. (MOBI)

Mobia Medical adds Myriam Curet, M.D., former Intuitive Surgical CMO, to board

Neutral Impact 2 of 5 leadership Written later

Effective July 30, 2026, Mobia Medical expanded its board from seven to eight members and appointed Myriam J. Curet, M.D. as a Class II director. The board determined she is independent, and she has not yet been named to any board committee.

Key points

Dr. Curet's term expires at the 2028 annual meeting of stockholders.
She retired in March 2026 as Executive Vice President and Chief Medical Officer of Intuitive Surgical, a role she held from November 2017.
She also sits on the boards of Inspire Medical Systems (since December 2023) and Stereotaxis (since July 2021).
She will receive compensation under Mobia's non-employee director program and is expected to sign the company's standard indemnification agreement.

The filing

CompanyMobia Medical, Inc. (MOBI)

Form8-K, current report

Filed with the SECAug 3, 2026, 5:20 PM ET

Accession number0001193125-26-330853

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.